← Leaderboards
Jennifer Wootton Hill
Beth Israel Deaconess Medical Center
$5,113,496
Attributed
$5,113,496
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $551.7K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,113,496 · 6
By mechanism
R01$3,781,286 · 2
R00$739,552 · 1
R21$363,991 · 1
F32$141,700 · 1
K99$86,967 · 1
Top collaborators
No co-investigators on record.
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Richard Spark$1,163,496
Others in their field
Top investigators on “Obesity”
- Chanza Baytop · Westat, Inc.$271,217,917
- Judith S. Currier · University Of California Los Angeles$139,907,800
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$137,892,773
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$108,827,660
- Peter Gordon Gillespie · Oregon Health And Science University$104,808,120
- Joseph E Robertson · Oregon Health & Science University$93,739,249
Research focus
ObesityLeptinInsulin ResistanceDiabetes MellitusInsulinReproductivePathway InteractionsNeuronsInsulin ReceptorBrainSignal TransductionResponsePreventPlayDiabeticReceptorHypothalamic StructureMaleNovel StrategiesFertilityMetabolicAreaBody WeightGenetic
Grant awards (20)
Astrocyte insulin resistance-induced neuroendocrine defects in pubertal delay and hypogonadotropic hypogonadism$536,227
R01 · FY2025 · HD · contact PI
Astrocyte insulin resistance-induced neuroendocrine defects in pubertal delay and hypogonadotropic hypogonadism$527,805
R01 · FY2024 · HD · contact PI
Astrocyte insulin resistance-induced neuroendocrine defects in pubertal delay and hypogonadotropic hypogonadism$551,677
R01 · FY2023 · HD · contact PI
Astrocyte insulin resistance-induced neuroendocrine defects in pubertal delay and hypogonadotropic hypogonadism$533,137
R01 · FY2022 · HD · contact PI
Defective melanocortin signaling underlying T2D-associated erectile dysfunction$323,543
R01 · FY2019 · HD · contact PI
Defective melanocortin signaling underlying T2D-associated erectile dysfunction$323,515
R01 · FY2018 · HD · contact PI
Defective melanocortin signaling underlying T2D-associated erectile dysfunction$294,412
R01 · FY2017 · HD · contact PI
Defective melanocortin signaling underlying T2D-associated erectile dysfunction$320,226
R01 · FY2016 · HD · contact PI
Defective melanocortin signaling underlying T2D-associated erectile dysfunction$34,430
R01 · FY2016 · HD · contact PI
Defective melanocortin signaling underlying T2D-associated erectile dysfunction$336,314
R01 · FY2015 · HD · contact PI
Inflammatory triggers of polycystic ovarian syndrome.$177,390
R21 · FY2013 · HD · contact PI
Inflammatory triggers of polycystic ovarian syndrome.$186,601
R21 · FY2012 · HD · contact PI
Hypothalamic leptin and insulin signals aligning metabolic state and fertility$244,044
R00 · FY2011 · HD · contact PI
Hypothalamic leptin and insulin signals aligning metabolic state and fertility$246,509
R00 · FY2010 · HD · contact PI
Hypothalamic leptin and insulin signals aligning metabolic state and fertility$248,999
R00 · FY2009 · HD · contact PI
Hypothalamic leptin and insulin signals aligning metabolic state and fertility$86,967
K99 · FY2008 · HD · contact PI
Hypothalamic Leptin and Insulin Signaling$50,428
F32 · FY2006 · DK · contact PI
Hypothalamic Leptin and Insulin Signaling$40,496
F32 · FY2005 · DK
Hypothalamic Leptin and Insulin Signaling$7,800
F32 · FY2005 · DK
Hypothalamic Leptin and Insulin Signaling$42,976
F32 · FY2004 · DK